Evidence map›Paper›PMID 31362387›Full record

ArticleCells2019

An Omics Approach to Extracellular Vesicles from HIV-1 Infected Cells.

Robert A Barclay, Pooja Khatkar, Gifty Mensah, Catherine DeMarino, Jeffery S C Chu, Benjamin Lepene, Weidong Zhou, Patrick Gillevet, Bahareh Torkzaban, Kamel Khalili and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Extracellular Vesicles Regulated by Viruses and Antiviral Strategies.Frontiers in cell and developmental biology · 2021
    Review
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Robert A BarclayLaboratory of Molecular Virology, George Mason University, Manassas, VA 20110, USA.
Pooja KhatkarLaboratory of Molecular Virology, George Mason University, Manassas, VA 20110, USA.
Gifty MensahLaboratory of Molecular Virology, George Mason University, Manassas, VA 20110, USA.
Catherine DeMarinoLaboratory of Molecular Virology, George Mason University, Manassas, VA 20110, USA.
Jeffery S C ChuApplied Biological Materials Inc., 1-3671 Viking Way, Richmond, BC V6V 2J5, Canada.
Benjamin LepeneCeres Nanosciences Inc., Manassas, VA 20110, USA.
Weidong ZhouCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA.
Patrick GillevetMicrobiome Analysis Center, George Mason University, Manassas, VA 20110, USA.
Bahareh TorkzabanCenter for Neurovirology, Temple University, Philadelphia, PA 19122, USA.
Kamel KhaliliCenter for Neurovirology, Temple University, Philadelphia, PA 19122, USA.
Lance LiottaCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA.
Fatah KashanchiLaboratory of Molecular Virology, George Mason University, Manassas, VA 20110, USA. fkashanc@gmu.edu.
George Mason University · USTemple University · USApplied Biological Materials (Canada) · CACeres Nanosciences · US

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Dietmar J Kappes · 1985 to 2026
$138.8M
HIV1 INHIBITION USING TAT PEPTIDE DERIVATIVESR01AI043894 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI KASHANCHI, FATAH · 1999 to 2015
$4.4M
HIV neuropathogenesis related to exosomes containing HIV non-coding RNAsR01NS099029 · NINDS · GEORGE MASON UNIVERSITY · PI KASHANCHI, FATAH · 2016 to 2020
$1.9M
Effect of chromatin remodelers/modifiers on HIV-1 Tat activated transcriptionR21AI074410 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI KASHANCHI, FATAH · 2009 to 2010
$432k
A radiation-induced cellular stress activates HIV and induces killing of infected cellsR21AI127351 · NIAID · GEORGE MASON UNIVERSITY · PI KASHANCHI, FATAH · 2016 to 2017
$418k
HIV-1 TAR derived miRNA: Implications for Latency and PathogenesisR21AI078859 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI KASHANCHI, FATAH · 2009 to 2010
$400k
The Effect of Antiretroviral Drugs on Exosome Release and Associated CNS DysfunctionF31NS109443 · NINDS · GEORGE MASON UNIVERSITY · PI DEMARINO, CATHERINE · 2019 to 2019
$22k
NCI NIH HHS P30 CA006927NIAID NIH HHS R01 AI043894NIAID NIH HHS R21 AI074410NIAID NIH HHS R21 AI078859NIAID NIH HHS R21 AI127351NINDS NIH HHS F31 NS109443NINDS NIH HHS R01 NS099029
6 · The paper itself

Abstract

Human Immunodeficiency Virus-1 (HIV-1) is the causative agent of Acquired Immunodeficiency Syndrome (AIDS), infecting nearly 37 million people worldwide. Currently, there is no definitive cure, mainly due to HIV-1's ability to enact latency. Our previous work has shown that exosomes, a small extracellular vesicle, from uninfected cells can activate HIV-1 in latent cells, leading to increased mostly short and some long HIV-1 RNA transcripts. This is consistent with the notion that none of the FDA-approved antiretroviral drugs used today in the clinic are transcription inhibitors. Furthermore, these HIV-1 transcripts can be packaged into exosomes and released from the infected cell. Here, we examined the differences in protein and nucleic acid content between exosomes from uninfected and HIV-1-infected cells. We found increased cyclin-dependent kinases, among other kinases, in exosomes from infected T-cells while other kinases were present in exosomes from infected monocytes. Additionally, we found a series of short antisense HIV-1 RNA from the 3' LTR that appears heavily mutated in exosomes from HIV-1-infected cells along with the presence of cellular noncoding RNAs and cellular miRNAs. Both physical and functional validations were performed on some of the key findings. Collectively, our data indicate distinct differences in protein and RNA content between exosomes from uninfected and HIV-1-infected cells, which can lead to different functional outcomes in recipient cells.

Indexed as

HIV-1Host-Pathogen InteractionsComputational BiologyExosomesExtracellular VesiclesGene Expression ProfilingGene Expression RegulationGene Regulatory NetworksHIV InfectionsHumansMonocytesProteomicsSignal TransductionT-Lymphocytesextracellular vesicleHIV-1proteomicsRNA sequencing

Identifiers

PMID31362387
PMCPMC6724219
OpenAlexW2966737673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.